Literature DB >> 16455646

TLR1- and TLR6-independent recognition of bacterial lipopeptides.

Ute Buwitt-Beckmann1, Holger Heine, Karl-Heinz Wiesmüller, Günther Jung, Roland Brock, Shizuo Akira, Artur J Ulmer.   

Abstract

Bacterial cell walls contain lipoproteins/peptides, which are strong modulators of the innate immune system. Triacylated lipopeptides are assumed to be recognized by TLR2/TLR1-, whereas diacylated lipopeptides use TLR2/TLR6 heteromers for signaling. Following our initial discovery of TLR6-independent diacylated lipopeptides, we could now characterize di- and triacylated lipopeptides (e.g. Pam(2)C-SK(4), Pam(3)C-GNNDESNISFKEK), which have stimulatory activity in TLR1- and in TLR6-deficient mice. Furthermore, for the first time, we present triacylated lipopeptides with short length ester-bound fatty acids (like PamOct(2)C-SSNASK(4)), which induce no response in TLR1-deficient cells. No differences in the phosphorylation of MAP kinases by lipopeptide analogs having different TLR2-coreceptor usage were observed. Blocking experiments indicated that different TLR2 heteromers recognize their specific lipopeptide ligands independently from each other. In summary, a triacylation pattern is necessary but not sufficient to render a lipopeptide TLR1-dependent, and a diacylation pattern is necessary but not sufficient to render a lipopeptide TLR6-dependent. Contrary to the current model, distinct lipopeptides are recognized by TLR2 in a TLR1- and TLR6-independent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455646     DOI: 10.1074/jbc.M512525200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  TLR2 activation inhibits embryonic neural progenitor cell proliferation.

Authors:  Eitan Okun; Kathleen J Griffioen; Tae Gen Son; Jong-Hwan Lee; Nicholas J Roberts; Mohamed R Mughal; Emmette Hutchison; Aiwu Cheng; Thiruma V Arumugam; Justin D Lathia; Henriette van Praag; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

2.  Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening.

Authors:  Yue Guan; Katherine Omueti-Ayoade; Sarita K Mutha; Paul J Hergenrother; Richard I Tapping
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

3.  Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.

Authors:  Inga Wilde; Sonja Lotz; David Engelmann; Andrea Starke; Ger van Zandbergen; Werner Solbach; Tamás Laskay
Journal:  Med Microbiol Immunol       Date:  2006-09-28       Impact factor: 3.402

4.  Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae.

Authors:  Takeshi Into; Jun-ichi Dohkan; Megumi Inomata; Misako Nakashima; Ken-ichiro Shibata; Kenji Matsushita
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

5.  A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.

Authors:  Claudia Guida; Sandro Altamura; Felix A Klein; Bruno Galy; Michael Boutros; Artur J Ulmer; Matthias W Hentze; Martina U Muckenthaler
Journal:  Blood       Date:  2015-02-06       Impact factor: 22.113

Review 6.  Mycoplasma lipoproteins and Toll-like receptors.

Authors:  Ling-ling Zuo; Yi-mou Wu; Xiao-xing You
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

7.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

9.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

10.  Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin.

Authors:  Hyun-Ju Jang; Hae-Suk Kim; Daniel H Hwang; Michael J Quon; Jeong-a Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.